The Gambian Genome Variation Project is a collaboration of the MRC Unit in The Gambia, the Wellcome Sanger Institute, the MRC Centre for Genomics and Global Health at Oxford University, and the MalariaGEN Resource Centre. The purpose of the project was to support the discovery and understanding of genetic variants that influence human disease. Specifically defined goals were:
The sequence data is 9x coverage of individuals from four Gambian populations.
The data is from the following European Nucleotide Archive (ENA) study IDs:
ERP001420 - Fula
ERP001781 - Jola
ERP002150 - Woloff
ERP002385 - Mandinka
Analysis of this data is described in the Malaria Genomic Epidemiology Network, 2019 publication.
If you have any questions please email email@example.com.